Effect of topical administration of 2% dorzlamide hydrochloride or 2% dorzlamide hydrochloride-0.5% timolol maleate on intraocular pressure in clinically normal horses

Objective-To evaluate the effect of topical administration of 2% dorzolamid e hydrochloride or 2% dorzolamide hydrochloride-0.5% timolol maleate on int raocular pressure (IOP) in clinically normal horses. Animals-18 healthy adult horses without ocular abnormalities. Procedure-The IOP was measured at 5 time points (7 AM, 9 AM, 11 AM, 3 PM, 7 PM) over 11 days. On days 1 and 2, baseline values were established. On da ys 3 through 5, horses received 2% dorzolamide HCl (group D, n = 9) or 2% d orzolamide HCl-0.5% timolol maleate (group DT, 9) in 1 randomly assigned ey e every 24 hours immediately following each daily 7 AM IOP measurement. On days 6 through 9, each drug was given every 12 hours (7 AM and 7 PM) in the treated eye. Measurements on days 10 and 11 assessed return to baseline. M ixed linear regression models compared mean IOP difference for each drug at each time period. Results-Mean IOP decreased significantly in all eyes during the 2 dose/d pe riod, compared with the baseline, 1 dose/d, and follow-up periods. Conclusions and Clinical Relevance-Administration of either drug every 24 h ours for short-term treatment does not reduce IOP significantly. Administer ing either drug every 12 hours induced a significant reduction of IOP; howe ver, controlling for all variables, the reduction was less than 2 mm Hg.